Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPOLI-2: Nanoliposomal Irinotecan, Fluorouracil, and Leucovorin in Advanced Biliary Tract Cancer
NCT04005339Phase 2Active, not recruiting
- Sponsor
- Georgetown University
- Start
- Jul 2019
- Primary completion
- Sep 2025
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nanoliposomal irinotecan in biliary tract cancer (BTC), sponsored by Georgetown University. Started Jul 2019; status: active, not recruiting.
02
Drugs
nanoliposomal irinotecan
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04005339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04005339.